Have lunch while listening to the latest information about specific drugs, devices, other products or services related to pulmonary, critical care or sleep medicine. Daily Product Theaters, Mini-Product Theaters and International Product Theatres will be held today, Monday and Tuesday in the Exhibit Hall. All of these events will include complimentary boxed lunches to be provided by the ATS (while quantities last).
Noon to 12:45 p.m.
Product Theater 1 (End of 100/200 aisles)
The Device Could Make a Difference for Your COPD Patients. Which Inhaler Device to Choose? The Experts Weigh In.
Speaker: Donald P. Tashkin, MD, Emeritus Professor of Medicine, Division of Pulmonary and Critical Care Medicine; Medical Director of the Pulmonary Function Laboratory, David Geffen School of Medicine at UCLA, Los Angeles, CA; Amir Sharafkhaneh, MD, PhD, Associate Professor of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, TX
Company: Dey Pharma, L.P.
Product Theater 2 (Beginning of 1600 aisle)
Practicing Evidence-Based Medicine in Asthma: Educating Our Referral Base
Recent trends in asthma indicate patient care remains suboptimal. Cooperation between leaders in asthma care and community-based practitioners has become increasingly important. Please join Dr. Michael Marcus for an interactive session examining the role pulmonary specialists have in educating their referral base on guideline recommendations for treating asthma patients.
Speaker: Dr. Michael Marcus, Maimonides Medical Center, Brooklyn, NY
Company: Sunovion Pharmaceuticals, Inc.
Noon to 12:20 p.m.
Mini-Product Theater (End of 1700 aisle)
PAH Case Study: Perspectives in Clinical Management and Treatment Options
With a leading expert, this program will feature an interactive patient case and discuss approaches to diagnosis, assessment, and treatment of Pulmonary Arterial Hypertension (PAH).
Speaker: Ernest A. Haeusslein, MD, FACC, Medical Director, Heart Failure/Transplantation Program, California Pacific Medical Center, San Francisco, CA
Company: Gilead Sciences, Inc.